Ironwood Pharmaceuticals is a small-cap GI-focused biotech with strong LINZESS sales but looming patent expiry by 2029–2030.

New Pacific Metals said it signed administrative mining contracts for its Carangas silver-gold project in Bolivia, an ...

CBRE Global Real Estate Income Fund downgraded to Hold: 15%+ yield, but rising ROC and rate uncertainty raise cut risk. Click ...

Australia's Yindjibarndi indigenous group said it lodged an appeal with the federal court over the compensation awarded ...

T-Mobile (TMUS) to lay off 77 workers in Washington and close select retail sites this fall, citing business needs.

Weis Markets upgraded to Hold as valuation tightens; margins improve but sales lag peers. Click to read my analysis for more ...

Explore quantum computing investing: why profits are years away, why broad/AI funds miss it, and how QTUM vs WQTM ETFs offer ...

Pzena Focused Value outperformed its benchmark in Q2 2026, driven by health care gains and new positions. Read the full ...

BNY Mellon Small/Mid Cap Growth Fund returned 23.09% in Q2 2026, slightly trailing its benchmark. Read the full analysis for ...

Cleveland-Cliffs is rated a Buy, capitalizing on improved fundamentals and a disconnect between price and operational ...

Melrose Industries PLC update: accident resolution, $100M claims fund, and strong aerospace/defense growth. Click for this ...

John Hancock Alternative Asset Allocation Fund registered a gain but underperformed its benchmark, the HFRX Global Hedge Fund ...